Interview: Matias Pino: Chief Financial Officer: POSIBL

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

Compass Completes FDA Application for COMP360

November 10th, 2026|

LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...

Vireo Growth Reports Q3 2026 Financial Results

November 10th, 2026|

MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...

Vireo Completes FLUENT Acquisition

November 10th, 2026|

MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...